Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryosuke Shinouchi

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Neuro Endocrinology Letters|December 31, 2024
Analysis of oxytocin and oxytocin receptor expressions after hand therapy treatment in a mouse model of chemotherapy-induced peripheral neuropathy Akiko Sasaki, Ryosuke Shinouchi, Koji Nobe, et al.
Journal of Pharmacological Sciences|July 26, 2025
SMTP-44D prevents negative symptoms of diabetic neuropathy by inhibiting sciatic nerve apoptosisAyaka Aoki, Keita Shibata, Ryosuke Shinouchi, et al.
Journal of Diabetes and Its Complications|May 3, 2025
Antioxidant and anti-inflammatory effects of SMTP-44D in a streptozotocin-induced diabetic neuropathy mouse modelRyosuke Shinouchi, Keita Shibata, Taiju Nagatsuka, et al.
International Journal of Molecular Sciences|May 14, 2022
SMTP-44D Exerts Antioxidant and Anti-Inflammatory Effects through Its Soluble Epoxide Hydrolase Inhibitory Action in Immortalized Mouse Schwann Cells upon High Glucose TreatmentRyosuke Shinouchi, Keita Shibata, Shiori Jono, et al.
Biological & Pharmaceutical Bulletin|January 12, 2026
SMTP-44D Improves High Glucose-Induced Vascular Endothelial DysfunctionShiori Jono, Ryosuke Shinouchi, Takashi Obama, et al.
Pharmacology Research & Perspectives|November 20, 2020
SMTP-44D improves diabetic neuropathy symptoms in mice through its antioxidant and anti-inflammatory activitiesRyosuke Shinouchi, Keita Shibata, Terumasa Hashimoto, et al.
Neuroscience Letters|February 22, 2023
The effect of hand therapy on alleviating chemotherapy-induced peripheral neuropathy in a model mouseRyosuke Shinouchi, Akiko Sasaki, Takashi Takaki, et al.
Pharmacology Research & Perspectives|March 20, 2022
Evaluation of in vitro transdermal permeation, mass spectrometric imaging, and in vivo analgesic effects of pregabalin using a pluronic lecithin organogel formulation in miceMichiru Nagao, Masataka Tajima, Erika Sugiyama, et al.
Brain, Behavior, and Immunity|March 5, 2026
The role of NLRP3 inflammasome in opioid-induced neurochemical markers, therapeutic effects, and adverse effects in male miceMyosotys Rodriguez, Dileepkumar Veeragoni, Candy Carbajal, et al.
Pharmaceuticals (Basel, Switzerland)|January 28, 2026
Characterization of Novel Sigma Receptor Ligands Derived from Multicomponent Reactions as Efficacious Treatments for Neuropathic PainRyosuke Shinouchi, Bengisu Turgutalp, Rohini S Ople, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Neuro Endocrinology Letters|December 31, 2024
Analysis of oxytocin and oxytocin receptor expressions after hand therapy treatment in a mouse model of chemotherapy-induced peripheral neuropathy Akiko Sasaki, Ryosuke Shinouchi, Koji Nobe, et al.
Journal of Pharmacological Sciences|July 26, 2025
SMTP-44D prevents negative symptoms of diabetic neuropathy by inhibiting sciatic nerve apoptosisAyaka Aoki, Keita Shibata, Ryosuke Shinouchi, et al.
Journal of Diabetes and Its Complications|May 3, 2025
Antioxidant and anti-inflammatory effects of SMTP-44D in a streptozotocin-induced diabetic neuropathy mouse modelRyosuke Shinouchi, Keita Shibata, Taiju Nagatsuka, et al.
International Journal of Molecular Sciences|May 14, 2022
SMTP-44D Exerts Antioxidant and Anti-Inflammatory Effects through Its Soluble Epoxide Hydrolase Inhibitory Action in Immortalized Mouse Schwann Cells upon High Glucose TreatmentRyosuke Shinouchi, Keita Shibata, Shiori Jono, et al.
Biological & Pharmaceutical Bulletin|January 12, 2026
SMTP-44D Improves High Glucose-Induced Vascular Endothelial DysfunctionShiori Jono, Ryosuke Shinouchi, Takashi Obama, et al.
Pharmacology Research & Perspectives|November 20, 2020
SMTP-44D improves diabetic neuropathy symptoms in mice through its antioxidant and anti-inflammatory activitiesRyosuke Shinouchi, Keita Shibata, Terumasa Hashimoto, et al.
Neuroscience Letters|February 22, 2023
The effect of hand therapy on alleviating chemotherapy-induced peripheral neuropathy in a model mouseRyosuke Shinouchi, Akiko Sasaki, Takashi Takaki, et al.
Pharmacology Research & Perspectives|March 20, 2022
Evaluation of in vitro transdermal permeation, mass spectrometric imaging, and in vivo analgesic effects of pregabalin using a pluronic lecithin organogel formulation in miceMichiru Nagao, Masataka Tajima, Erika Sugiyama, et al.
Brain, Behavior, and Immunity|March 5, 2026
The role of NLRP3 inflammasome in opioid-induced neurochemical markers, therapeutic effects, and adverse effects in male miceMyosotys Rodriguez, Dileepkumar Veeragoni, Candy Carbajal, et al.
Pharmaceuticals (Basel, Switzerland)|January 28, 2026
Characterization of Novel Sigma Receptor Ligands Derived from Multicomponent Reactions as Efficacious Treatments for Neuropathic PainRyosuke Shinouchi, Bengisu Turgutalp, Rohini S Ople, et al.
Pageof 2